12R-LOX over-expression has been reported in various pathologies such as psoriasis, proliferative dermatitis as well as pulmonary obstructive diseases indicating that this enzyme plays significant role in pathogenesis of inflammatory diseases. 12R-LOX, therefore, is a suitable target for therapeutic intervention with potential application of its inhibitors in the treatment of skin and other inflammatory disorders. Identification of such inhibitors requires sufficient quantity of active enzyme to be produced by an easy and cost effective expression systems and further development of a robust assay system to screen inhibitors against the 12R-LOX enzyme. Therefore, in the present study, a prokaryotic expression system was developed to over-express and purify active human 12R-LOX enzyme by a single step purification process. We have further standardized an HPLC based assay system to assess the activity of purified human 12R-LOX enzyme. We show here that purified 12R-LOX preferentially utilizes free arachidonic acid as the substrate but it is also active on methyl ester of arachidonic acid, albeit less efficiently. Additionally, using this assay system we observed the potent inhibition of human 12R-LOX enzyme activity by the ethyl acetate and aqueous sub-fractions of Acalypha indica leaves, which is widely used in traditional medicines for the treatment of various skin ailments PeerJ Preprints | https://doi.org/10.7287/peerj.preprints.2906v1 | CC BY 4.0 Open Access |
50 hepoxilins. These products are involved in myriad of biological events like immunity, 51 inflammation, cell differentiation and proliferation [3, 4, 5] . Lipoxygenases stereo-and 52 regioselectively oxygenate the substrate, arachidonic acid, and are thus named as 5-, 8-, 12-and 53 15-LOX [6] . 12R-Lipoxygenase (12R-LOX), is unique in incorporation of molecular oxygen on 54 substrate arachidonic acid, R-stereospecifically, to produce 12R-Hydroperoxyeicosatetraencoic 55 acid (12R-HPETE), which is acted upon by another epidermal lipoxygenase , eLOX-3, to 56 generate hepoxilins, the potent signaling molecules [7, 8] .
57
12R-LOX has drawn much attention due to its inductive role in oxidising complex lipids 58 thereby modifying membrane structure, which is critical for maturation, differentiation, 59 induction of inflammatory pathways as well as proliferative potential of the skin cells 60 [9, 10, 11, 12] . Pivotal role of 12R-LOX in skin physiology came into light with the discovery of 61 high levels of 12R-HETE in psoriatic skin cells and also in various carcinoma cell lines 62 [13, 14, 15] . Additionally, high 12R-LOX activity has also been involved in pathogenesis of 63 pulmonary obstructive diseases where it has been established that 12R-LOX stimulates mucin 64 production by ERK activation and sp1 translocation [16] . From the above studies it appears that 65 a critical amount of 12R-LOX enzyme activity is essential for maintaining cell homeostasis and 66 overexpression of the same leads to pathological conditions. Thus, 12R-LOX represents a 67 suitable target for therapeutic intervention where 12R-LOX inhibitors will be potential agents of 68 therapeutic value in such pathologies. 128 After washing the column to remove non-specific proteins, the 12R-LOX protein was eluted with 129 buffer containing 250mM imidazole, which displaces the His-tag fusion protein from the matrix. 154 Sri Venkateswara University, Tirupati. After collection these leaves were washed and sun-dried 155 for 5-7 days. Coarse powder of these leaves was prepared in grinding machine.
Preparation of different solvent extracts of Acalypha indica
157 Grounded powder of the leaves of Acalypha indica weighing 250g was tightly packed to the 1/3 158 volume of the soxhlet apparatus and solvents with different polarity were used to extract the 159 products. Methanol, ethanol, chloroform, hexane, ethyl acetate and water were used as the 160 solvents for extraction. The extracted fractions were dried to remove the respective solvents.
161 Each fraction was then dissolved in DMSO solvent. These fractions with different chemical 208 control for the experiment (Fig. 3B) . Commercially bought 12R-HETE (Cayman Chemical 209 Company, Ann Arbor, MI, USA) was injected and run on RP-HPLC for the standard (Fig. 3A) .
210 Peak 'Y' denotes 12R-HETE product. RP-HPLC analysis of the incubation of the cell extracts 211 with free acid form of arachidonic acid showed the formation of 12R-HETE peak as only product 212 with ~300 mAU at 235 nm ( Fig. 3D -product specific peak is marked as Y). We didn't observe 213 any 12R-HETE product peak when methyl ester of arachidonic acid was used as the substrate 214 (Fig. 3C) . Chromatograms for both negative control and experimental when methyl ester of 215 arachidonic acid (AA) as the substrate showed similar patterns (Compare Fig. 3B and Fig. 3C ).
216
Then purified enzyme was used to do RP-HPLC assay with both the substrates. (Fig. 4) .
217 200 g/ml of purified h-12R-LOX enzyme was incubated with 0.1 mM substrates and products 218 were analysed on RP-HPLC. 12R-HETE product peak 'Y' (~350-400 mAU) was observed when 219 free arachidonic acid (AA) was used as the substrate (Fig. 4C) . Notably, we could also see a 220 product peak when methyl arachidonate was used as a substrate though absorbance of the peak 221 was limited to only~50 mAU (Fig. 4B) . While using purified enzyme as the enzyme source for 222 our assays, we saw two common peaks 'X' and 'Z' in all the chromatograms including negative 223 control (without substrate) (Fig.4A) . NDGA (nordihydroguaiaretic acid), which is a standard 224 LOX inhibitor was used in order to confirm the nature of the peak. The addition of NDGA 225 inhibited the formation of 12R-HETE product confirming that the peak 'Y' which appears is 226 indeed a lipoxygenase product peak (Fig. 4D) . 
246
Considering the importance of 12R-LOX enzyme, present study was undertaken to 247 produce sufficient quantities of lipoxygenase enzyme in cost effective and less time consuming 248 manner, so that the active enzyme can be used for various purposes such as biochemical studies, 249 identification of its inhibitors from natural sources, crystallization studies etc. Human 12R-250 lipoxygenase was identified from human keratinocytes. Although it was cloned and expressed in 251 Hela cells but the enzyme showed very low catalytic activity [1] . Subsequently, Sun and co-252 workers cloned both murine and human 12R-LOX and expressed in HEK293 and COS-M6 cells 253 but were unable to detect any enzyme activity [32] . Smita and co-workers, observed endogenous 254 overexpression of 12R-LOX in an epidermoid carcinoma cell line A431 [15] . We used the cell 255 lysate of A431 cell line as the enzyme source for human 12R-LOX, but were unable to detect 256 any enzymatic activity using HPLC assay system. Redox conditions or reducing factors or 257 inhibitory factors present in whole cell lysate could be possibly inhibiting the enzyme activity.
258 Other reports show that baculovirus system can be used to produce active 12R-LOX enzyme, 259 which can be used for biochemical studies, but this method of enzyme production is laborious, 260 costly and labor intensive. Meruvu and co-workers cloned and expressed murine 12R-LOX in E. 269 Notably, we were able to produce this sufficient amount of protein without co-expressing 270 chaperons as was done by Deb and co-workers [23]. Our assay system confirms that the 271 overexpressed recombinant protein was fully active which suggests that expressed proteins are in 272 their proper conformations.
273
Biochemical characterization of both human and mouse 12R-LOX enzymes has been 274 done previously by different groups. Boeglin and co-workers have shown that the human12R-275 LOX enzyme, purified from baculovirus, utilised arachidonic acid as the substrate but with low 276 catalytic activity [7] . They couldn't see any activity with methyl ester of AA. Siebert and co-277 workers have shown that mouse 12R-LOX metabolizes methyl ester of arachidonic acid as the 278 substrate and does not utilize free AA [20] . Our results are consistent with earlier observations 279 as we found that free AA is the preferred substrate of human 12R-LOX enzyme in our assay 280 conditions. In addition to that we could also see week activity of human 12R-LOX enzyme on 281 methyl ester of AA, which has never been reported earlier. In earlier studies, the amount of 282 enzyme expression was limiting and since we have found out that human 12R-LOX has a very 283 low activity with methyl ester of AA, we suspect the limitation of enzyme was the reason in 284 earlier studies for not getting any activity when methyl ester of AA was used as a substrate. 
319
In summary, we have successfully expressed and purified fully active, human 12R-LOX 320 enzyme in native conditions, using a bacterial expression system. It is evident from our results 321 that human-12R-LOX preferentially utilizes arachidonic acid and also exhibits very low catalytic 322 activity towards arachidonic acid methyl ester. Importantly, using cell-free HPLC based assay was assessed by incubating it with substrate arachidonic acid. In different ex
